2 results
Approved WMOCompleted
Our study aim is to assess whether it is feasible to remove small breast cancers completely using the BLES system under US guidance.
Approved WMOWill not start
The purpose of this study is to evaluate the possible risks and efficacy (improvement of disease) with an experimental oral study drug named eliglustat in pediatric patients from 2 to 18 years with Gaucher disease.